2021
DOI: 10.1002/yea.3562
|View full text |Cite
|
Sign up to set email alerts
|

How to characterize a strain? Clonal heterogeneity in industrial Saccharomyces influences both phenotypes and heterogeneity in phenotypes

Abstract: Populations of microbes are constantly evolving heterogeneity that selection acts upon, yet heterogeneity is nontrivial to assess methodologically. The necessary practice of isolating single‐cell colonies and thus subclone lineages for establishing, transferring, and using a strain results in single‐cell bottlenecks with a generally neglected effect on the characteristics of the strain itself. Here, we present evidence that various subclone lineages for industrial yeasts sequenced for recent genomic studies sh… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 95 publications
2
5
0
Order By: Relevance
“…All samples were void of extensive subculturing to prevent accumulation of mutations and genome structure variations during lab propagation. Furthermore, as clonal heterogeneity even in single batches of commercial yeasts may be prevalent [35], we used two different subclone isolates of each of the probiotic yeast products available in the country. Detailed patient and isolation data enabled us to compare non-mycosis and mycosis clinical samples as well.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…All samples were void of extensive subculturing to prevent accumulation of mutations and genome structure variations during lab propagation. Furthermore, as clonal heterogeneity even in single batches of commercial yeasts may be prevalent [35], we used two different subclone isolates of each of the probiotic yeast products available in the country. Detailed patient and isolation data enabled us to compare non-mycosis and mycosis clinical samples as well.…”
Section: Discussionmentioning
confidence: 99%
“…Stocks of the clinical and commercial isolates were saved at −70 • C in YPD broth (VWR Chemicals, Solon, OH, USA, pH 5.8) supplemented with 30% glycerol. These commercial and clinical isolates were subcultured only once (multiple single-cell bottlenecks were avoided) to prevent accumulation of potential geno-and phenotypic changes in the samples due to the phenomenon of clonal heterogeneity that was recently demonstrated for yeast strains [35]. A list of the isolates used in this study is presented in Table 1.…”
Section: Isolates and Patient Datamentioning
confidence: 99%
See 1 more Smart Citation
“…Stocks of the commercial and clinical isolates and deletion mutants were saved at −70 °C in YPD broth (VWR Chemicals, Solon, OH, USA, pH 5.8) supplemented with 30% glycerol. Subculturing was minimalized in order to prevent the geno- and phenotypic changes that might be a result of clonal heterogeneity [ 45 ]. Isolates were divided into three groups according to Imre et al [ 10 ]: a commercial (C; PY0001, PY0002), a non-mycosis (NM; 465/2018, 2251/2018), and a mycosis group (M; DE6507, DE35762).…”
Section: Methodsmentioning
confidence: 99%
“…Next, median coverages of all genes in the annotation of the PY0001 assembly were calculated with BEDTools. Gene copy number variations were inferred from this data as follows (adapted from [ 45 ]). Medians of the median coverages of the upstream and downstream 20 genes along with the genes in question (altogether 41 genes) were calculated for each gene (for the first and last 20 genes of each PY0001 chromosome, medians of the median coverages of the first and last 41 genes of the chromosome, respectively, were used).…”
Section: Methodsmentioning
confidence: 99%